Nu Skin Enterprises, Inc (NYSE: NUS) has seen a decline in its stock price by -2.07 in relation to its previous close of 7.48. However, the company has experienced a 13.57% gain in its stock price over the last five trading sessions. seekingalpha.com reported 2024-11-11 that Nu Skin Enterprises, Inc. demonstrates a tested business model with long-term free cash flow generation, supported by acquisitions, new products, and digital transformation. Despite recent earnings disappointments, optimistic 2025-2026 EPS growth projections and multiple revenue catalysts suggest significant upside potential in the company’s valuation. The company’s global market expansion, cash acquisitions of LifeDNA and BeautyBio, and innovative product launches are key drivers for future net sales growth.
Is It Worth Investing in Nu Skin Enterprises, Inc (NYSE: NUS) Right Now?
Additionally, the 36-month beta value for NUS is 1.19. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 2 rating it as “overweight,” 1 rating it as “hold,” and 1 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for NUS is 48.65M and currently, short sellers hold a 3.20% ratio of that float. The average trading volume of NUS on November 14, 2024 was 1.07M shares.
NUS’s Market Performance
The stock of Nu Skin Enterprises, Inc (NUS) has seen a 13.57% increase in the past week, with a 14.45% rise in the past month, and a -25.18% fall in the past quarter. The volatility ratio for the week is 7.62%, and the volatility levels for the past 30 days are at 4.95% for NUS. The simple moving average for the last 20 days is 12.56% for NUS stock, with a simple moving average of -32.62% for the last 200 days.
Analysts’ Opinion of NUS
Many brokerage firms have already submitted their reports for NUS stocks, with Jefferies repeating the rating for NUS by listing it as a “Hold.” The predicted price for NUS in the upcoming period, according to Jefferies is $39 based on the research report published on January 31, 2023 of the previous year 2023.
BofA Securities gave a rating of “Neutral” to NUS, setting the target price at $58 in the report published on October 02nd of the previous year.
NUS Trading at 8.53% from the 50-Day Moving Average
After a stumble in the market that brought NUS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -64.70% of loss for the given period.
Volatility was left at 4.95%, however, over the last 30 days, the volatility rate increased by 7.62%, as shares surge +15.36% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.55% lower at present.
During the last 5 trading sessions, NUS rose by +13.21%, which changed the moving average for the period of 200-days by -60.66% in comparison to the 20-day moving average, which settled at $6.51. In addition, Nu Skin Enterprises, Inc saw -62.28% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NUS starting from LIPMAN ANDREW D, who sale 2,000 shares at the price of $13.33 back on May 28 ’24. After this action, LIPMAN ANDREW D now owns 23,225 shares of Nu Skin Enterprises, Inc, valued at $26,660 using the latest closing price.
WOODBURY EDWINA D, the Director of Nu Skin Enterprises, Inc, sale 1,693 shares at $12.02 during a trade that took place back on May 02 ’24, which means that WOODBURY EDWINA D is holding 18,095 shares at $20,350 based on the most recent closing price.
Stock Fundamentals for NUS
Current profitability levels for the company are sitting at:
- 0.05 for the present operating margin
- 0.71 for the gross margin
The net margin for Nu Skin Enterprises, Inc stands at -0.06. The total capital return value is set at 0.07. Equity return is now at value -13.50, with -6.11 for asset returns.
Based on Nu Skin Enterprises, Inc (NUS), the company’s capital structure generated 0.42 points at debt to capital in total, while cash flow to debt ratio is standing at 0.28. The debt to equity ratio resting at 0.71. The interest coverage ratio of the stock is 4.41.
Currently, EBITDA for the company is 137.66 million with net debt to EBITDA at -9.75. When we switch over and look at the enterprise to sales, we see a ratio of 0.36. The receivables turnover for the company is 25.8for trailing twelve months and the total asset turnover is 1.12. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.93.
Conclusion
In conclusion, Nu Skin Enterprises, Inc (NUS) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
